Umetrics Announces MODDE® 10 Software Release

Malmö, Sweden — Umetrics announces a new version of MODDE, a state of the art, off-the-shelf, Windows based software solution for Design of Experiments (DOE). MODDE 10 sets a new standard for ease of use with user friendly wizards which take the user through all the steps of planning, analyzing, interpreting and understanding the results. [...]

Allotrope Foundation partners with Osthus Inc. to develop state-of-the-art open framework for laboratory data

WASHINGTON -- Allotrope Foundation – a consortium of leading pharmaceutical and biotech companies – selected Osthus Inc. as the architect of its much anticipated open framework for laboratory data. The scope of services that Osthus will provide includes consulting services to Allotrope, as well as the design, coding and implementation of the framework. "During the [...]

SEQUENOM ANNOUNCES REVIEW OF STRATEGIC ALTERNATIVES FOR ITS GENETIC ANALYSIS BUSINESS SEGMENT

SAN DIEGO -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that its Board of Directors has authorized a review of potential strategic alternatives for its Genetic Analysis business segment. The review will include evaluation of a full range of potential strategic alternatives for the [...]

BioLife Solutions and SAVSU Technologies Announce Exclusive Distribution Agreement

BOTHELL, Wash. and SANTE FE, N.M. -- BioLife Solutions, Inc. (otcqb:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media products for cells and tissues, and contract aseptic media manufacturer, and SAVSU Technologies, Inc., a subsidiary of Barson Corporation, today jointly announced an agreement wherein BioLife will exclusively [...]

Centrillion Biosciences Launches Cloud and Mobile-based Sequencing Application

Palo Alto, CA -- Based on data compiled from results of many targeted re-sequencing and exome experiments, users can search using gene symbols, synonyms and gene descriptions giving a visual display of coverage of specific target regions. In addition to providing coverage data, mSeq(TM) reports in a handy summary view of searched gene regions. Features [...]

Accelrys Brings Next-Generation Decision-making to Scientific Discovery with Launch of Accelrys Insight

LONDON -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced Accelrys Insight and Accelrys Insight for Excel, completing the roll-out of Accelrys' next-generation cheminformatics suite and providing an interactive, collaborative environment for rapid and effective decision-making in drug discovery. Accelrys Insight and Accelrys Insight for Excel offer research [...]

TGR BioSciences Announces License Agreement with Abcam

ADELAIDE, Australia -- TGR BioSciences Pty Ltd (TGR), a leading developer of advanced cell-based assay technologies, is pleased to announce a license agreement with Abcam plc, of Cambridge, UK, a producer and distributor of high quality protein research tools. Under the agreement Abcam will develop and manufacture immunoassay products that incorporate TGR's proprietary CaptSure(TM) assay [...]

New Generation Phenom Desktop SEM from Nanoscience Instruments

Phoenix, AZ -- Nanoscience Instruments today announced the new generation Phenom Desktop Scanning Electron Microscope (SEM). With a magnification range up to 100,000x and resolution better than 17nm, the Phenom Pro is the most powerful desktop SEM ever. Not only does the Phenom provide remarkable clarity and detail, it is also lightning fast, extremely intuitive, [...]

Luminex Corporation Receives FDA and European Clearance for a New Personalized Medicine Genotyping Assay, xTAG® CYP2C19 Kit

AUSTIN, Texas -- Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA and European clearance for a comprehensive genotyping assay, xTAG® CYP2C19 Kit. This new test enables a personalized approach to aid physicians in determining patient treatment plans based on certain genetic variants of the P450 2C19 gene. "Since cytochrome [CYP450] enzymes are [...]

Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory

Shirley, NY -- After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (https://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official signing ceremony will held on Oct. 1. According to protocols, Luciferase from Vibrio fischeri has been used in a [...]

Access IBO on Knowledge Center